Funds to reduce cholesterol, prevent the development of lung cancer

Researchers from Queen's University Belfast state: the administration of drugs that reduce cholesterol in the blood, prevents the development of lung cancer. The information has been confirmed under observation for 14 thousands of patients with cancer.

In the study, scientists examined the effect of drugs from other groups on the course of cancer. It turned out the reception of funds that affect the level of cholesterol, has an impact on Oncology. Cancer mortality with regular intake of drugs against high cholesterol was lower by 19%. Abolish the primary treatment of speech, the researchers note, not a speech. Patients received all the care in cancer.

The results can differ from the truth, so scientists plan to conduct another study involving a larger number of subjects, writes Diabetes Insider.

Subscribe to new posts: